Predictors of ICS use in the month following discharge from the ED
| Crude OR | Adjusted OR | 95% CI | |
|---|---|---|---|
| *All adjusted odds ratios were obtained from a unique GEE model, implying that each variable is adjusted for all other variables in the table. | |||
| Sociodemographic variables | |||
| Age at ED visit (13–17/5–12 years) | 0.49 | 0.50 | 0.44 to 0.57 |
| Sex (male/female) | 1.16 | 1.02 | 0.91 to 1.15 |
| Social assistance (yes/no) | 0.93 | 0.96 | 0.86 to 1.08 |
| Living on Montreal Island (yes/no) | 0.96 | 0.79 | 0.69 to 0.91 |
| Co-morbidity (yes/no) | 1.08 | 1.09 | 0.93 to 1.27 |
| Severity of the exacerbation | |||
| Consultation with paediatrician or respiratory physician (yes/no) | 1.22 | 1.04 | 0.89 to 1.22 |
| Prescription of oral corticosteroids (yes/no) | 2.74 | 2.31 | 2.05 to 2.60 |
| Use of ICS 6 months before ED visit (yes/no) | 3.48 | 2.35 | 2.06 to 2.69 |
| Markers of asthma severity and control during 6 months before ED visit | |||
| Oral corticosteroids (yes/no) | 2.35 | 1.45 | 1.22 to 1.72 |
| Short acting β2 agonists (>10/⩽10 doses per week) | 2.40 | 1.57 | 1.34 to 1.83 |
| Long acting β2 agonists (yes/no) | 2.05 | 1.17 | 0.63 to 2.15 |
| Hospital admission for asthma (yes/no) | 1.95 | 0.88 | 0.66 to 1.18 |
| ED visit for asthma (yes/no) | 1.35 | 0.86 | 0.74 to 1.00 |
| Medical visit to a paediatrician or a respiratory physician (yes/no) | 2.71 | 1.67 | 1.44 to 1.93 |